Educational information, not medical advice — ask your doctor or midwife.
Pseudoephedrine is a decongestant. It unblocks a stuffy nose for a few hours. Most people use it for colds, sinus pressure and hay fever.
It is not a herb. It is a single purified chemical. It was first drawn from ephedra plants, known in Chinese medicine as ma huang, and is now mostly made in a lab.
The short evidence verdict: in people, it gives a small but real drop in nasal stuffiness for a few days. It does not shorten a cold. It does not treat the infection behind it.
Ephedra itself has a long history of use for blocked noses and wheezing. Long use in a tradition is not proof that a thing works. It is also not proof that it is safe.
Pseudoephedrine sits in an odd spot. It is sold over the counter in many countries, yet it carries real heart and blood pressure risks. It is also controlled by law, because it can be used to make illegal methamphetamine.
It shrinks swollen blood vessels in the lining of your nose. Those swollen vessels are what make a cold feel blocked. Less swelling means more room for air.
It does this by acting on alpha receptors, which are switches on blood vessel walls that tell them to tighten. This effect has been measured in people, not just in test tubes.
The same switch exists elsewhere in the body. That is why the drug can also lift your blood pressure, speed your heart and keep you awake.
It does nothing to the virus or to the allergy itself. It eases one symptom while your body deals with the cause.
It comes in several forms:
- plain tablets, taken every four to six hours - slow-release tablets, taken every twelve hours - liquids and syrups, often for children - combined cold and flu tablets, capsules and sachets - hot drink powders
In most countries you ask a pharmacist for it. In the United States it sits behind the counter, and you show photo ID.
Some brands now sell a look-alike product with phenylephrine instead. That swap matters. Oral phenylephrine performed no better than a dummy pill in US review panels, so check which drug is actually in the box.
Ephedra, or ma huang, was used in Chinese medicine for well over a thousand years. Healers gave it for blocked noses, chills and wheezing.
In 1885, the Japanese chemist Nagai Nagayoshi isolated ephedrine from the plant. Pseudoephedrine was identified in the same family of work. Both were studied in the West in the 1920s.
From the 1950s onward, pseudoephedrine became a standard pharmacy decongestant. It largely replaced ephedrine for this job, as it was gentler on the heart.
From the 1990s, criminal labs began buying it in bulk to make methamphetamine. Governments answered with purchase limits, ID checks and pharmacy-only sales. That is why it is harder to buy now than it was in 1990.
Stop and get emergency help now if you have:
- chest pain, or a pounding or racing heart that will not settle - sudden severe headache, blurred vision or confusion - weakness on one side, a drooping face or slurred speech - sudden severe belly pain with bloody diarrhoea - a fit (seizure), or hallucinations - a sudden inability to pass urine
Stop and see your doctor or pharmacist soon if you have:
- a blocked nose that is no better after seven days - a fever, face pain or green discharge that is getting worse - blood pressure readings higher than your normal range - nights of lost sleep or a jittery feeling that will not pass
If a child has taken more than the label amount, call a poisons line or emergency services straight away.
In the United States it is sold behind the pharmacy counter under the 2005 Combat Methamphetamine Epidemic Act, with ID checks and monthly purchase limits. In the UK, Australia and much of the EU it is a pharmacy-only medicine with pack size limits. Mexico and Japan restrict or ban it, and it is banned in competitive sport above a set urine level.
Evidence grades and traditional-use labels are explained in our methodology. Nothing here is medical advice.
What it is typically used for, usual dose, cautions, and the study behind it where real trial data exists.
One email with the summary. We'll also send a short weekly evidence update — unsubscribe any time.